By Kelly Cloonan Cue Biopharma has received positive feedback from the Food and Drug Administration for its first in-human trial design for CUE-401, a protein that aims to treat autoimmune disease.

In this captivating video, we delve into the mesmerizing world of living statue art, focusing on the positive reactions that these incredible performers elicit from passersby. Witness the ...

Insmed reports positive top-line results in a Phase 2b study for a pulmonary arterial hypertension drug.

Taysha Gene Therapies Announces Pivotal Part B Trial Design Details for TSHA-102 in Rett Syndrome Enabled by IRSF Natural History Data and Positive Clinical Data from Part A of the REVEAL Adult ...

The ASA Experimental Design Exhibition 2025 will officially open on Tuesday, April 29th at the IMPACT Arena Exhibition and Convention Center in Greater Bangkok, Thailand.

This document provides the public with notice that, on March 3, 2025, Long Island Rail Road (LIRR) submitted a request for amendment (RFA) to its FRA-certified positive train control (PTC) system. FRA ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic diseases marked by too low levels of specific cellular proteins. To boost ...

US Army Special Forces' soldiers are able to control UASs using their voices with Primordial Labs' Anura software. (Janes/Meredith Roaten) Soldiers will test a voice command software paired with ...

This paper presents the theory and analysis related to the aggregated macroscopic fundamental diagram and presents specific implications for traffic control. The paper presents the aggregation results ...